Annual EBITDA:
$9.11B-$2.19B(-19.36%)Summary
- As of today, GSK annual EBITDA is $9.11 billion, with the most recent change of -$2.19 billion (-19.36%) on December 31, 2024.
- During the last 3 years, GSK annual EBITDA has risen by +$192.00 million (+2.15%).
- GSK annual EBITDA is now -53.74% below its all-time high of $19.70 billion, reached on December 31, 2015.
Performance
GSK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$4.46B+$624.05M(+16.26%)Summary
- As of today, GSK quarterly EBITDA is $4.46 billion, with the most recent change of +$624.05 million (+16.26%) on September 1, 2025.
- Over the past year, GSK quarterly EBITDA has increased by +$2.61 billion (+140.50%).
- GSK quarterly EBITDA is now -9.38% below its all-time high of $4.92 billion, reached on September 30, 2011.
Performance
GSK Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$14.54B+$2.61B(+21.83%)Summary
- As of today, GSK TTM EBITDA is $14.54 billion, with the most recent change of +$2.61 billion (+21.83%) on September 1, 2025.
- Over the past year, GSK TTM EBITDA has increased by +$3.09 billion (+27.01%).
- GSK TTM EBITDA is now -18.41% below its all-time high of $17.83 billion, reached on June 30, 2008.
Performance
GSK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GSK EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -19.4% | +140.5% | +27.0% |
| 3Y3 Years | +2.1% | +10.3% | +30.7% |
| 5Y5 Years | -24.3% | +17.9% | +55.7% |
GSK EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -19.4% | +2.1% | at high | +290.5% | at high | +41.6% |
| 5Y | 5-Year | -24.3% | +2.1% | at high | +290.5% | at high | +55.7% |
| All-Time | All-Time | -53.7% | >+9999.0% | -9.4% | +179.8% | -18.4% | +5904.4% |
GSK EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $4.46B(+16.3%) | $14.54B(+21.8%) |
| Jun 2025 | - | $3.84B(+2.9%) | $11.94B(+4.6%) |
| Mar 2025 | - | $3.73B(+48.3%) | $11.41B(+4.8%) |
| Dec 2024 | $9.11B(-19.4%) | $2.52B(+35.6%) | $10.89B(-4.9%) |
| Sep 2024 | - | $1.86B(-44.0%) | $11.45B(-13.0%) |
| Jun 2024 | - | $3.31B(+3.1%) | $13.17B(+5.1%) |
| Mar 2024 | - | $3.21B(+4.4%) | $12.54B(+2.7%) |
| Dec 2023 | $11.30B(+6.1%) | $3.08B(-13.9%) | $12.20B(+18.8%) |
| Sep 2023 | - | $3.57B(+33.4%) | $10.27B(-4.4%) |
| Jun 2023 | - | $2.68B(-7.0%) | $10.74B(-0.9%) |
| Mar 2023 | - | $2.88B(+152.0%) | $10.84B(+1.6%) |
| Dec 2022 | $10.65B(+19.4%) | $1.14B(-71.8%) | $10.67B(-4.1%) |
| Sep 2022 | - | $4.05B(+45.9%) | $11.13B(+5.4%) |
| Jun 2022 | - | $2.77B(+2.2%) | $10.56B(+0.8%) |
| Mar 2022 | - | $2.71B(+69.4%) | $10.48B(+1.4%) |
| Dec 2021 | $8.92B(-13.8%) | $1.60B(-53.9%) | $10.33B(-13.3%) |
| Sep 2021 | - | $3.47B(+29.3%) | $11.92B(-2.5%) |
| Jun 2021 | - | $2.69B(+4.5%) | $12.22B(+25.3%) |
| Mar 2021 | - | $2.57B(-19.2%) | $9.75B(-5.6%) |
| Dec 2020 | $10.35B(-14.0%) | $3.18B(-15.9%) | $10.33B(+10.6%) |
| Sep 2020 | - | $3.78B(+1661.8%) | $9.34B(+4.4%) |
| Jun 2020 | - | $214.81M(-93.2%) | $8.95B(-25.5%) |
| Mar 2020 | - | $3.15B(+43.5%) | $12.02B(-6.0%) |
| Dec 2019 | $12.05B(+22.8%) | $2.19B(-35.3%) | $12.79B(-4.6%) |
| Sep 2019 | - | $3.39B(+3.3%) | $13.41B(+1.6%) |
| Jun 2019 | - | $3.28B(-16.2%) | $13.20B(+6.6%) |
| Mar 2019 | - | $3.92B(+39.0%) | $12.38B(+8.8%) |
| Dec 2018 | $9.81B(+22.8%) | $2.82B(-11.2%) | $11.37B(-1.1%) |
| Sep 2018 | - | $3.18B(+28.9%) | $11.50B(-1.0%) |
| Jun 2018 | - | $2.46B(-15.4%) | $11.62B(-2.4%) |
| Mar 2018 | - | $2.91B(-1.2%) | $11.91B(+6.3%) |
| Dec 2017 | $7.98B(+33.0%) | $2.95B(-10.5%) | $11.21B(+4.6%) |
| Sep 2017 | - | $3.30B(+19.8%) | $10.72B(+6.8%) |
| Jun 2017 | - | $2.75B(+24.4%) | $10.04B(-1.1%) |
| Mar 2017 | - | $2.21B(-9.9%) | $10.14B(-4.3%) |
| Dec 2016 | $6.00B(-69.5%) | $2.46B(-6.1%) | $10.60B(+29.4%) |
| Sep 2016 | - | $2.62B(-8.5%) | $8.19B(+3.7%) |
| Jun 2016 | - | $2.86B(+7.0%) | $7.90B(-0.7%) |
| Mar 2016 | - | $2.67B(+5768.5%) | $7.96B(+6.1%) |
| Dec 2015 | $19.70B(+131.8%) | $45.50M(-98.0%) | $7.50B(-32.2%) |
| Sep 2015 | - | $2.33B(-20.3%) | $11.05B(-8.7%) |
| Jun 2015 | - | $2.92B(+31.8%) | $12.11B(+2.4%) |
| Mar 2015 | - | $2.21B(-38.6%) | $11.83B(-7.0%) |
| Dec 2014 | $8.50B(-38.3%) | $3.60B(+6.6%) | $12.71B(+51.0%) |
| Sep 2014 | - | $3.38B(+28.2%) | $8.42B(-6.6%) |
| Jun 2014 | - | $2.64B(-14.9%) | $9.02B(-8.7%) |
| Mar 2014 | - | $3.10B(+549.2%) | $9.88B(-3.6%) |
| Dec 2013 | $13.77B(-1.3%) | -$689.39M(-117.3%) | $10.25B(-33.2%) |
| Sep 2013 | - | $3.98B(+13.9%) | $15.35B(+5.7%) |
| Jun 2013 | - | $3.49B(+0.6%) | $14.53B(+0.1%) |
| Mar 2013 | - | $3.47B(-21.4%) | $14.51B(+2.1%) |
| Dec 2012 | $13.95B(-11.9%) | $4.41B(+39.9%) | $14.21B(+39.4%) |
| Sep 2012 | - | $3.15B(-9.1%) | $10.20B(-14.8%) |
| Jun 2012 | - | $3.47B(+9.4%) | $11.97B(-3.2%) |
| Mar 2012 | - | $3.17B(+700.1%) | $12.36B(-0.0%) |
| Dec 2011 | $15.84B(+82.8%) | $396.66M(-91.9%) | $12.36B(+24.9%) |
| Sep 2011 | - | $4.92B(+27.3%) | $9.90B(+13.0%) |
| Jun 2011 | - | $3.87B(+21.7%) | $8.76B(+58.1%) |
| Mar 2011 | - | $3.18B(+253.5%) | $5.54B(-7.9%) |
| Dec 2010 | $8.67B(-46.0%) | -$2.07B(-154.6%) | $6.02B(-48.1%) |
| Sep 2010 | - | $3.79B(+487.3%) | $11.60B(-2.6%) |
| Jun 2010 | - | $645.08M(-82.3%) | $11.90B(-17.2%) |
| Mar 2010 | - | $3.65B(+4.1%) | $14.38B(+0.2%) |
| Dec 2009 | $16.03B(-0.7%) | $3.51B(-14.3%) | $14.34B(+0.9%) |
| Sep 2009 | - | $4.09B(+31.2%) | $14.22B(+30.9%) |
| Jun 2009 | - | $3.12B(-13.8%) | $10.86B(-10.3%) |
| Mar 2009 | - | $3.62B(+7.0%) | $12.10B(-5.8%) |
| Dec 2008 | $16.15B(-12.5%) | $3.38B(+359.6%) | $12.85B(-8.3%) |
| Sep 2008 | - | $735.66M(-83.1%) | $14.01B(-21.4%) |
| Jun 2008 | - | $4.37B(-0.1%) | $17.83B(+1.3%) |
| Mar 2008 | - | $4.37B(-3.7%) | $17.60B(+0.0%) |
| Dec 2007 | $18.46B(+14.3%) | $4.54B(-0.4%) | $17.59B(+8.5%) |
| Sep 2007 | - | $4.56B(+10.1%) | $16.22B(+2.1%) |
| Jun 2007 | - | $4.14B(-5.2%) | $15.88B(+0.4%) |
| Mar 2007 | - | $4.36B(+37.8%) | $15.82B(+1.8%) |
| Dec 2006 | $16.16B(+600.6%) | $3.17B(-24.9%) | $15.55B(-0.5%) |
| Sep 2006 | - | $4.22B(+3.5%) | $15.63B(+6.4%) |
| Jun 2006 | - | $4.07B(-0.4%) | $14.69B(+2.9%) |
| Mar 2006 | - | $4.09B(+26.0%) | $14.28B(+5.8%) |
| Dec 2005 | $2.31B | $3.25B(-0.9%) | $13.49B(+9.9%) |
| Sep 2005 | - | $3.28B(-10.4%) | $12.28B(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2005 | - | $3.66B(+10.8%) | $12.25B(+4.3%) |
| Mar 2005 | - | $3.30B(+62.6%) | $11.75B(-0.1%) |
| Dec 2004 | $12.12B(+2.3%) | $2.03B(-37.6%) | $11.77B(-12.3%) |
| Sep 2004 | - | $3.26B(+3.1%) | $13.42B(-1.0%) |
| Jun 2004 | - | $3.16B(-4.9%) | $13.56B(-1.3%) |
| Mar 2004 | - | $3.32B(-10.1%) | $13.73B(+1.4%) |
| Dec 2003 | $11.84B(+20.6%) | $3.69B(+8.8%) | $13.54B(+5.4%) |
| Sep 2003 | - | $3.39B(+1.8%) | $12.85B(+7.1%) |
| Jun 2003 | - | $3.33B(+6.6%) | $12.00B(+6.1%) |
| Mar 2003 | - | $3.13B(+4.2%) | $11.31B(+6.8%) |
| Dec 2002 | $9.82B(-1.4%) | $3.00B(+18.1%) | $10.59B(-0.8%) |
| Sep 2002 | - | $2.54B(-3.7%) | $10.68B(+2.6%) |
| Jun 2002 | - | $2.64B(+9.6%) | $10.41B(+3.0%) |
| Mar 2002 | - | $2.41B(-22.1%) | $10.11B(+6.8%) |
| Dec 2001 | $9.96B(-7.5%) | $3.09B(+36.1%) | $9.46B(-8.5%) |
| Sep 2001 | - | $2.27B(-2.9%) | $10.34B(+6.3%) |
| Jun 2001 | - | $2.34B(+32.5%) | $9.73B(+3.6%) |
| Mar 2001 | - | $1.77B(-55.5%) | $9.40B(-4.1%) |
| Dec 2000 | $10.77B(+107.5%) | $3.97B(+138.9%) | $9.80B(+3945.8%) |
| Sep 2000 | - | $1.66B(-17.2%) | $242.24M(-89.1%) |
| Jun 2000 | - | $2.00B(-7.6%) | $2.23B(+53.9%) |
| Mar 2000 | - | $2.17B(+138.8%) | $1.45B(-43.6%) |
| Dec 1999 | $5.19B(-3.0%) | -$5.59B(-253.4%) | $2.57B(-16.0%) |
| Sep 1999 | - | $3.65B(+197.7%) | $3.05B(+8.8%) |
| Jun 1999 | - | $1.22B(-62.7%) | $2.81B(+2.5%) |
| Mar 1999 | - | $3.29B(+164.4%) | $2.74B(+4.1%) |
| Dec 1998 | $5.36B(-0.5%) | -$5.11B(-250.1%) | $2.63B(+10.6%) |
| Sep 1998 | - | $3.40B(+194.3%) | $2.38B(+6.6%) |
| Jun 1998 | - | $1.16B(-63.7%) | $2.23B(-48.9%) |
| Mar 1998 | - | $3.18B(+159.3%) | $4.37B(-3.5%) |
| Dec 1997 | $5.38B(-5.6%) | -$5.36B(-264.7%) | $4.53B(-35.7%) |
| Sep 1997 | - | $3.25B(-1.1%) | $7.04B(-8.0%) |
| Jun 1997 | - | $3.29B(-1.4%) | $7.65B(+1.4%) |
| Mar 1997 | - | $3.34B(+217.3%) | $7.55B(+1.1%) |
| Dec 1996 | $5.70B(+10.9%) | -$2.85B(-173.6%) | $7.47B(-27.6%) |
| Sep 1996 | - | $3.87B(+21.3%) | $10.31B(+14.5%) |
| Jun 1996 | - | $3.19B(-2.1%) | $9.01B(+1745.6%) |
| Mar 1996 | - | $3.26B(+27.0%) | $488.17M(-79.4%) |
| Dec 1995 | $5.14B(+58.9%) | - | - |
| Sep 1995 | - | $2.56B(+148.1%) | $2.37B(+1.4%) |
| Jun 1995 | - | -$5.33B(-310.9%) | $2.34B(-41.0%) |
| Mar 1995 | - | $2.53B(-3.3%) | $3.97B(+7.2%) |
| Dec 1994 | - | $2.61B(+3.3%) | $3.70B(+15.4%) |
| Sep 1994 | - | $2.53B(+168.3%) | $3.21B(+15.8%) |
| Jun 1994 | $3.23B(+1.7%) | -$3.71B(-263.9%) | $2.77B(-14.6%) |
| Mar 1994 | - | $2.26B(+6.6%) | $3.24B(+1.0%) |
| Dec 1993 | - | $2.12B(+1.3%) | $3.21B(+10.8%) |
| Sep 1993 | - | $2.09B(+164.8%) | $2.90B(+8.7%) |
| Jun 1993 | $3.18B(+7.5%) | -$3.23B(-245.0%) | $2.66B(+5.8%) |
| Mar 1993 | - | $2.23B(+23.3%) | $2.52B(+10.9%) |
| Dec 1992 | - | $1.81B(-2.9%) | $2.27B(-1.8%) |
| Sep 1992 | - | $1.86B(+155.1%) | $2.31B(-0.5%) |
| Jun 1992 | $2.96B(+5.6%) | -$3.38B(-270.5%) | $2.33B(-41.3%) |
| Mar 1992 | - | $1.98B(+7.2%) | $3.96B(+13.4%) |
| Dec 1991 | - | $1.85B(-1.3%) | $3.49B(+15.1%) |
| Sep 1991 | - | $1.87B(+207.3%) | $3.03B(+19.9%) |
| Jun 1991 | $2.80B(+27.6%) | -$1.75B(-215.4%) | $2.53B(-0.9%) |
| Mar 1991 | - | $1.51B(+8.7%) | $2.55B(+9.2%) |
| Dec 1990 | - | $1.39B(+1.5%) | $2.34B(+9.3%) |
| Sep 1990 | - | $1.37B(+179.5%) | $2.14B(+9.4%) |
| Jun 1990 | $2.19B(+13.6%) | -$1.72B(-232.7%) | $1.96B(-20.5%) |
| Mar 1990 | - | $1.30B(+8.8%) | $2.46B(+12.8%) |
| Dec 1989 | - | $1.19B(+0.5%) | $2.18B(+9.3%) |
| Sep 1989 | - | $1.19B(+197.3%) | $1.99B(+9.3%) |
| Jun 1989 | $1.93B(+18.9%) | -$1.22B(-219.8%) | $1.82B(-9.2%) |
| Mar 1989 | - | $1.02B(+1.1%) | $2.01B(+8.3%) |
| Dec 1988 | - | $1.01B(-1.1%) | $1.85B(+11.6%) |
| Sep 1988 | - | $1.02B(+198.4%) | $1.66B(+10.4%) |
| Jun 1988 | $1.62B(+31.1%) | -$1.03B(-219.8%) | $1.51B(-10.5%) |
| Mar 1988 | - | $863.72M(+6.1%) | $1.68B(+9.7%) |
| Dec 1987 | - | $814.42M(-5.5%) | $1.53B(+13.5%) |
| Sep 1987 | - | $862.23M(+200.4%) | $1.35B(+16.3%) |
| Jun 1987 | $1.24B(+30.1%) | -$858.44M(-220.2%) | $1.16B(-7.3%) |
| Mar 1987 | - | $714.30M(+12.9%) | $1.25B(+15.9%) |
| Dec 1986 | - | $632.59M(-6.0%) | $1.08B(+8.4%) |
| Sep 1986 | - | $672.76M(+187.7%) | $995.94M(+15.3%) |
| Jun 1986 | $951.97M(>+9900.0%) | -$767.31M(-241.6%) | $863.62M(-47.0%) |
| Mar 1986 | - | $542.04M(-1.2%) | $1.63B(+49.8%) |
| Dec 1985 | - | $548.45M(+1.5%) | $1.09B(+101.5%) |
| Sep 1985 | - | $540.44M | $540.44M |
| Jun 1985 | $0.00(0.0%) | - | - |
| Jun 1984 | $0.00 | - | - |
FAQ
- What is GSK plc annual EBITDA?
- What is the all-time high annual EBITDA for GSK plc?
- What is GSK plc annual EBITDA year-on-year change?
- What is GSK plc quarterly EBITDA?
- What is the all-time high quarterly EBITDA for GSK plc?
- What is GSK plc quarterly EBITDA year-on-year change?
- What is GSK plc TTM EBITDA?
- What is the all-time high TTM EBITDA for GSK plc?
- What is GSK plc TTM EBITDA year-on-year change?
What is GSK plc annual EBITDA?
The current annual EBITDA of GSK is $9.11B
What is the all-time high annual EBITDA for GSK plc?
GSK plc all-time high annual EBITDA is $19.70B
What is GSK plc annual EBITDA year-on-year change?
Over the past year, GSK annual EBITDA has changed by -$2.19B (-19.36%)
What is GSK plc quarterly EBITDA?
The current quarterly EBITDA of GSK is $4.46B
What is the all-time high quarterly EBITDA for GSK plc?
GSK plc all-time high quarterly EBITDA is $4.92B
What is GSK plc quarterly EBITDA year-on-year change?
Over the past year, GSK quarterly EBITDA has changed by +$2.61B (+140.50%)
What is GSK plc TTM EBITDA?
The current TTM EBITDA of GSK is $14.54B
What is the all-time high TTM EBITDA for GSK plc?
GSK plc all-time high TTM EBITDA is $17.83B
What is GSK plc TTM EBITDA year-on-year change?
Over the past year, GSK TTM EBITDA has changed by +$3.09B (+27.01%)